Check out the corporations making headlines earlier than the opening bell : Metsera , Pfizer — The weight-loss drugmaker soared 60% after an announcement it might be purchased by Pfizer for $4.9 billion in money. The deal is predicted to shut in the fourth quarter. Pfizer shares ticked practically 3% larger. Anywhere , Compass — Brokerage big Compass plans to take over rival Anywhere, the mum or dad of Century 21 and Coldwell Banker, for $1.6 billion in an all-stock transaction. The mixed firm is predicted to have an enterprise worth of roughly $10 billion, together with the assumption of debt. Anywhere shares shot up greater than 50%, whereas Compass shares dipped about 9%. Sarepta Therapeutics — The biotech firm climbed 6% after an improve to outperform by BMO, which additionally known as for the inventory to greater than double. “SRPT’s current valuation renders its risk/reward skewed to the upside,” the funding financial institution mentioned. Crown Castle — The cell tower operator added 1.1% on the again of Wolfe Research’s improve to outperform from peer carry out. Wolfe mentioned the inventory is buying and selling at a great entry level. Kenvue — The Tylenol maker fell 5% after the Washington Post reported the Trump administration plans to announce Monday that use of the painkiller by pregnant ladies is linked to autism. Fox Corporation — President Donald Trump mentioned in a Sunday interview that conservative media baron Rupert Murdoch and his son Lachlan, the chief government of Fox Corp., are prone to be concerned in the deal to save lots of TikTok in the U.S . Fox Corp shares gained practically 4% in premarket buying and selling. Applied Materials — Shares gained greater than 1% after a Morgan Stanley improve to chubby from equal weight. The funding financial institution famous that the chipmaker trades at a lovely valuation relative to friends. — CNBC’s Alex Harring, Fred Imbert and Michelle Fox contributed reporting.